{
    "ticker": "NVRO",
    "name": "NeuroMetrix, Inc.",
    "description": "NeuroMetrix, Inc. is a healthcare company focused on innovative solutions for chronic pain management and neurological disorders. Founded in 1996, NeuroMetrix is renowned for its expertise in neurodiagnostics and wearable technology aimed at improving the quality of life for patients with chronic pain and peripheral neuropathy. The company's flagship product, Quell, is a wearable pain relief device that utilizes neuromodulation to provide relief from chronic pain without the use of medications. This FDA-cleared device is designed for use during the day and night, allowing users to manage their pain effectively. In addition to Quell, NeuroMetrix develops and markets the DPNCheck, a point-of-care device that aids in the early detection of diabetic peripheral neuropathy, which is a common complication of diabetes. With a strong emphasis on research and development, NeuroMetrix continues to explore new technologies and applications in the field of neurostimulation and pain management. The company's mission is to empower patients with effective, non-invasive solutions for pain relief and to improve healthcare outcomes through innovative technology.",
    "industry": [
        "Healthcare",
        "Medical Devices"
    ],
    "headquarters": "Waltham, Massachusetts, USA",
    "founded": "1996",
    "website": "https://www.neurometrix.com",
    "ceo": "Shai Gozani",
    "social_media": {
        "twitter": "https://twitter.com/Neurometrix",
        "linkedin": "https://www.linkedin.com/company/neurometrix/"
    },
    "investor_relations": "https://www.neurometrix.com/investors",
    "key_executives": [
        {
            "name": "Shai Gozani",
            "position": "CEO"
        },
        {
            "name": "Sandeep P. M. Ganguly",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Pain Management Devices",
            "products": [
                "Quell"
            ]
        },
        {
            "category": "Diagnostic Devices",
            "products": [
                "DPNCheck"
            ]
        }
    ],
    "seo": {
        "meta_title": "NeuroMetrix, Inc. | Innovative Pain Management Solutions",
        "meta_description": "Explore NeuroMetrix, Inc., a leader in chronic pain management and neurodiagnostics. Discover innovative products like Quell and DPNCheck for effective healthcare solutions.",
        "keywords": [
            "NeuroMetrix",
            "Chronic Pain Management",
            "Wearable Technology",
            "Quell",
            "DPNCheck",
            "Neuromodulation"
        ]
    },
    "faq": [
        {
            "question": "What is NeuroMetrix known for?",
            "answer": "NeuroMetrix is known for its innovative pain management solutions, particularly the Quell device for chronic pain relief."
        },
        {
            "question": "Who is the CEO of NeuroMetrix?",
            "answer": "Shai Gozani is the CEO of NeuroMetrix, Inc."
        },
        {
            "question": "Where is NeuroMetrix headquartered?",
            "answer": "NeuroMetrix is headquartered in Waltham, Massachusetts, USA."
        },
        {
            "question": "What are NeuroMetrix's main products?",
            "answer": "NeuroMetrix's main products include the Quell pain relief device and the DPNCheck diagnostic device."
        },
        {
            "question": "When was NeuroMetrix founded?",
            "answer": "NeuroMetrix was founded in 1996."
        }
    ],
    "competitors": [
        "AXGN",
        "STIM",
        "IRBT"
    ],
    "related_stocks": [
        "AAPL",
        "MSFT",
        "AMGN",
        "JNJ"
    ]
}